{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:26:23Z","timestamp":1793067983412,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006112","name":"Microsoft Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006112","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Blood malignancies arise from the dysregulation of haematopoiesis. The type of blood cell and the specific order of oncogenic events initiating abnormal growth ultimately determine the cancer subtype and subsequent clinical outcome. HOXA9 plays an important role in acute myeloid leukaemia (AML) prognosis by promoting blood cell expansion and altering differentiation; however, the function of HOXA9 in other blood malignancies is still unclear. Here, we highlight the biological switch and prognosis marker properties of HOXA9 in AML and chronic myeloproliferative neoplasms (MPN). First, we establish the ability of HOXA9 to stratify AML patients with distinct cellular and clinical outcomes. Then, through the use of a computational network model of MPN, we show that the self-activation of HOXA9 and its relationship to JAK2 and TET2 can explain the branching progression of JAK2\/TET2 mutant MPN patients towards divergent clinical characteristics. Finally, we predict a connection between the RUNX1 and MYB genes and a suppressive role for the NOTCH pathway in MPN diseases.<\/jats:p>","DOI":"10.1038\/s41467-022-33189-w","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T11:03:01Z","timestamp":1664794981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["HOXA9 has the hallmarks of a biological switch with implications in blood cancers"],"prefix":"10.1038","volume":"13","author":[{"given":"Laure","family":"Talarmain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2582-9689","authenticated-orcid":false,"given":"Matthew A.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Shorthouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilia","family":"Cabrera-Cosme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7871-8811","authenticated-orcid":false,"given":"David G.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4477-9047","authenticated-orcid":false,"given":"Jasmin","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0355-2946","authenticated-orcid":false,"given":"Benjamin A.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,3]]},"reference":[{"key":"33189_CR1","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1056\/NEJMra1406186","volume":"376","author":"JL Spivak","year":"2017","unstructured":"Spivak, J. L. Myeloproliferative neoplasms. N. Engl. J. Med. 376, 2168\u20132181 (2017).","journal-title":"N. Engl. J. Med."},{"key":"33189_CR2","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/s41375-018-0019-y","volume":"32","author":"A Tefferi","year":"2018","unstructured":"Tefferi, A. et al. Blast phase myeloproliferative neoplasm: Mayo-agimm study of 410 patients from two separate cohorts. Leukemia 32, 1200\u20131210 (2018).","journal-title":"Leukemia"},{"key":"33189_CR3","doi-asserted-by":"crossref","unstructured":"Yogarajah, M. & Tefferi, A. Leukemic transformation in myeloproliferative neoplasms: a literature review on risk, characteristics, and outcome. in Mayo Clinic Proceedings, vol. 92, pp. 1118\u20131128 (Elsevier, 2017).","DOI":"10.1016\/j.mayocp.2017.05.010"},{"key":"33189_CR4","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1182\/blood-2014-05-579136","volume":"124","author":"A Tefferi","year":"2014","unstructured":"Tefferi, A. et al. Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis. Blood 124, 2507\u20132513 (2014).","journal-title":"Blood"},{"key":"33189_CR5","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1038\/leu.2013.163","volume":"27","author":"A Tefferi","year":"2013","unstructured":"Tefferi, A. et al. Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study. Leukemia 27, 1874\u20131881 (2013).","journal-title":"Leukemia"},{"key":"33189_CR6","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1200\/JCO.2010.34.5298","volume":"29","author":"T Barbui","year":"2011","unstructured":"Barbui, T. et al. Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study. J. Clin. Oncol. 29, 3179\u20133184 (2011).","journal-title":"J. Clin. Oncol."},{"key":"33189_CR7","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1242\/dmm.015974","volume":"7","author":"CS Grove","year":"2014","unstructured":"Grove, C. S. & Vassiliou, G. S. Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer?. Dis. Model. Mech. 7, 941\u2013951 (2014).","journal-title":"Dis. Model. Mech."},{"key":"33189_CR8","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00277-005-1099-0","volume":"84","author":"U Bacher","year":"2005","unstructured":"Bacher, U. et al. Further correlations of morphology according to fab and who classification to cytogenetics in de novo acute myeloid leukemia: a study on 2235 patients. Ann. Hematol. 84, 785\u2013791 (2005).","journal-title":"Ann. Hematol."},{"key":"33189_CR9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/bjh.15276","volume":"182","author":"J Aynardi","year":"2018","unstructured":"Aynardi, J. et al. Jak2 v617f-positive acute myeloid leukaemia (aml): a comparison between de novo aml and secondary aml transformed from an underlying myeloproliferative neoplasm. a study from the bone marrow pathology group. Br. J. Haematol. 182, 78\u201385 (2018).","journal-title":"Br. J. Haematol."},{"key":"33189_CR10","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1182\/asheducation-2017.1.447","volume":"2017","author":"RC Lindsley","year":"2017","unstructured":"Lindsley, R. C. Uncoding the genetic heterogeneity of myelodysplastic syndrome. Hematol. Am. Soc. Hematol. Educ. Program Book 2017, 447\u2013452 (2017).","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program Book"},{"key":"33189_CR11","doi-asserted-by":"publisher","first-page":"a027060","DOI":"10.1101\/cshperspect.a027060","volume":"7","author":"DG Kent","year":"2017","unstructured":"Kent, D. G. & Green, A. R. Order matters: the order of somatic mutations influences cancer evolution. Cold Spring Harb. Perspect. Med. 7, a027060 (2017).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"33189_CR12","doi-asserted-by":"crossref","unstructured":"Clarke, M. A., Woodhouse, S., Piterman, N., Hall, B. A. & Fisher, J. Using state space exploration to determine how gene regulatory networks constrain mutation order in cancer evolution in Automated reasoning for systems biology and medicine. pp. 133\u2013153 (Springer, 2019).","DOI":"10.1007\/978-3-030-17297-8_5"},{"key":"33189_CR13","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1056\/NEJMoa1412098","volume":"372","author":"CA Ortmann","year":"2015","unstructured":"Ortmann, C. A. et al. Effect of mutation order on myeloproliferative neoplasms. N. Engl. J. Med. 372, 601\u2013612 (2015).","journal-title":"N. Engl. J. Med."},{"key":"33189_CR14","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1182\/blood-2009-04-216606","volume":"115","author":"C Bach","year":"2010","unstructured":"Bach, C. et al. Leukemogenic transformation by hoxa cluster genes. Blood 115, 2910\u20132918 (2010).","journal-title":"Blood"},{"key":"33189_CR15","doi-asserted-by":"crossref","unstructured":"Lewis, E. W. A gene complex controlling segmentation in drosophila in Genes, development and cancer. pp. 205\u2013217 (Springer, 1978).","DOI":"10.1007\/978-1-4419-8981-9_13"},{"key":"33189_CR16","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00109-014-1181-y","volume":"92","author":"S Bhatlekar","year":"2014","unstructured":"Bhatlekar, S., Fields, J. Z. & Boman, B. M. Hox genes and their role in the development of human cancers. J. Mol. Med. 92, 811\u2013823 (2014).","journal-title":"J. Mol. Med."},{"key":"33189_CR17","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1126\/science.286.5439.531","volume":"286","author":"TR Golub","year":"1999","unstructured":"Golub, T. R. et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286, 531\u2013537 (1999).","journal-title":"Science"},{"key":"33189_CR18","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2007-09-113597","volume":"113","author":"J Faber","year":"2009","unstructured":"Faber, J. et al. Hoxa9 is required for survival in human mll-rearranged acute leukemias. Blood 113, 2375\u20132385 (2009).","journal-title":"Blood"},{"key":"33189_CR19","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1038\/leu.2017.62","volume":"31","author":"Y Shima","year":"2017","unstructured":"Shima, Y., Yumoto, M., Katsumoto, T. & Kitabayashi, I. Mll is essential for nup98-hoxa9-induced leukemia. Leukemia 31, 2200\u20132210 (2017).","journal-title":"Leukemia"},{"key":"33189_CR20","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1182\/bloodadvances.2018025866","volume":"2","author":"X Zhong","year":"2018","unstructured":"Zhong, X. et al. Hoxa9 transforms murine myeloid cells by a feedback loop driving expression of key oncogenes and cell cycle control genes. Blood Adv. 2, 3137\u20133148 (2018).","journal-title":"Blood Adv."},{"key":"33189_CR21","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"C. G. A. R. Network.","year":"2013","unstructured":"C. G. A. R. Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med. 368, 2059\u20132074 (2013).","journal-title":"N. Engl. J. Med."},{"key":"33189_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/15592294.2017.1413517","volume":"13","author":"K Rejlova","year":"2018","unstructured":"Rejlova, K. et al. Low hox gene expression in pml-rar\u03b1-positive leukemia results from suppressed histone demethylation. Epigenetics 13, 73\u201384 (2018).","journal-title":"Epigenetics"},{"key":"33189_CR23","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/sj.leu.2403377","volume":"18","author":"A Lasa","year":"2004","unstructured":"Lasa, A. et al. Meis 1 expression is downregulated through promoter hypermethylation in aml1-eto acute myeloid leukemias. Leukemia 18, 1231\u20131237 (2004).","journal-title":"Leukemia"},{"key":"33189_CR24","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1182\/blood-2002-03-0772","volume":"100","author":"JC Byrd","year":"2002","unstructured":"Byrd, J. C. et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from cancer and leukemia group b (calgb 8461) presented in part at the 43rd annual meeting of the american society of hematology, orlando, fl, december 10, 2001, and published in abstract form. 59. Blood 100, 4325\u20134336 (2002).","journal-title":"Blood"},{"key":"33189_CR25","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1182\/blood-2007-07-102798","volume":"111","author":"Z-Y Wang","year":"2008","unstructured":"Wang, Z.-Y. & Chen, Z. Acute promyelocytic leukemia: from highly fatal to highly curable. Blood 111, 2505\u20132515 (2008).","journal-title":"Blood"},{"key":"33189_CR26","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","volume":"7","author":"RL Levine","year":"2005","unstructured":"Levine, R. L. et al. Activating mutation in the tyrosine kinase jak2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 7, 387\u2013397 (2005).","journal-title":"Cancer Cell"},{"key":"33189_CR27","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","volume":"360","author":"F Delhommeau","year":"2009","unstructured":"Delhommeau, F. et al. Mutation in tet2 in myeloid cancers. N. Engl. J. Med. 360, 2289\u20132301 (2009).","journal-title":"N. Engl. J. Med."},{"key":"33189_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12185-016-2122-z","volume":"105","author":"S Chiba","year":"2017","unstructured":"Chiba, S. Dysregulation of tet2 in hematologic malignancies. Int. J. Hematol. 105, 17\u201322 (2017).","journal-title":"Int. J. Hematol."},{"key":"33189_CR29","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1039\/C8IB00026C","volume":"10","author":"YZ Paterson","year":"2018","unstructured":"Paterson, Y. Z. et al. A toolbox for discrete modelling of cell signalling dynamics. Integr. Biol. 10, 370\u2013382 (2018).","journal-title":"Integr. Biol."},{"key":"33189_CR30","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/nature02089","volume":"426","author":"W Xiong","year":"2003","unstructured":"Xiong, W. & Ferrell, J. E. A positive-feedback-based bistable memory module that governs a cell fate decision. Nature 426, 460\u2013465 (2003).","journal-title":"Nature"},{"key":"33189_CR31","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1093\/emboj\/21.9.2159","volume":"21","author":"S Zhao","year":"2002","unstructured":"Zhao, S. et al. Jak2, complemented by a second signal from c-kit or flt-3, triggers extensive self-renewal of primary multipotential hemopoietic cells. EMBO J. 21, 2159\u20132167 (2002).","journal-title":"EMBO J."},{"key":"33189_CR32","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1158\/2159-8290.CD-17-0583","volume":"8","author":"CE de Bock","year":"2018","unstructured":"de Bock, C. E. et al. Hoxa9 cooperates with activated jak\/stat signaling to drive leukemia development. Cancer Discov. 8, 616\u2013631 (2018).","journal-title":"Cancer Discov."},{"key":"33189_CR33","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1038\/oncsis.2014.49","volume":"3","author":"L Bei","year":"2014","unstructured":"Bei, L. et al. Regulation of cdx4 gene transcription by hoxa9, hoxa10, the mll-ell oncogene and shp2 during leukemogenesis. Oncogenesis 3, e135\u2013e135 (2014).","journal-title":"Oncogenesis"},{"key":"33189_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms1826","volume":"3","author":"MT Bocker","year":"2012","unstructured":"Bocker, M. T. et al. Hydroxylation of 5-methylcytosine by tet2 maintains the active state of the mammalian hoxa cluster. Nat. Commun. 3, 1\u201312 (2012).","journal-title":"Nat. Commun."},{"key":"33189_CR35","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nature09999","volume":"473","author":"A Klinakis","year":"2011","unstructured":"Klinakis, A. et al. A novel tumour-suppressor function for the notch pathway in myeloid leukaemia. Nature 473, 230\u2013233 (2011).","journal-title":"Nature"},{"key":"33189_CR36","doi-asserted-by":"crossref","unstructured":"Chastagner, P., Israel, A. & Brou, C. Aip4\/itch regulates notch receptor degradation in the absence of ligand. PloS ONE 3, e2735 (2008).","DOI":"10.1371\/journal.pone.0002735"},{"key":"33189_CR37","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1073\/pnas.0510664103","volume":"103","author":"E Gallagher","year":"2006","unstructured":"Gallagher, E., Gao, M., Liu, Y.-C. & Karin, M. Activation of the e3 ubiquitin ligase itch through a phosphorylation-induced conformational change. Proc. Natl Acad. Sci. 103, 1717\u20131722 (2006).","journal-title":"Proc. Natl Acad. Sci."},{"key":"33189_CR38","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.bjhh.2014.10.001","volume":"37","author":"RM de Freitas","year":"2015","unstructured":"de Freitas, R. M. & da Costa Maranduba, C. M. Myeloproliferative neoplasms and the jak\/stat signaling pathway: an overview. Rev. Bras. Hematol. Hemoter. 37, 348\u2013353 (2015).","journal-title":"Rev. Bras. Hematol. Hemoter."},{"key":"33189_CR39","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1182\/blood.V90.5.1828","volume":"90","author":"T Bellon","year":"1997","unstructured":"Bellon, T., Perrotti, D. & Calabretta, B. Granulocytic differentiation of normal hematopoietic precursor cells induced by transcription factor pu. 1 correlates with negative regulation of the c-myb promoter. Blood 90, 1828\u20131839 (1997).","journal-title":"Blood"},{"key":"33189_CR40","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1182\/blood-2005-06-2516","volume":"107","author":"W Zhao","year":"2006","unstructured":"Zhao, W., Kitidis, C., Fleming, M. D., Lodish, H. F. & Ghaffari, S. Erythropoietin stimulates phosphorylation and activation of gata-1 via the pi3-kinase\/akt signaling pathway. Blood 107, 907\u2013915 (2006).","journal-title":"Blood"},{"key":"33189_CR41","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nm997","volume":"10","author":"M Ichikawa","year":"2004","unstructured":"Ichikawa, M. et al. Aml-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat. Med. 10, 299\u2013304 (2004).","journal-title":"Nat. Med."},{"key":"33189_CR42","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.4049\/jimmunol.180.7.4402","volume":"180","author":"M Ichikawa","year":"2008","unstructured":"Ichikawa, M. et al. Aml1\/runx1 negatively regulates quiescent hematopoietic stem cells in adult hematopoiesis. J. Immunol. 180, 4402\u20134408 (2008).","journal-title":"J. Immunol."},{"key":"33189_CR43","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1182\/blood-2014-04-567024","volume":"125","author":"E Chen","year":"2015","unstructured":"Chen, E. et al. Distinct effects of concomitant jak2v617f expression and tet2 loss in mice promote disease progression in myeloproliferative neoplasms. Blood 125, 327\u2013335 (2015).","journal-title":"Blood"},{"key":"33189_CR44","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1158\/2159-8290.CD-18-1138","volume":"9","author":"JJ Jeong","year":"2019","unstructured":"Jeong, J. J. et al. Cytokine-regulated phosphorylation and activation of tet2 by jak2 in hematopoiesis. Cancer Discov. 9, 778\u2013795 (2019).","journal-title":"Cancer Discov."},{"key":"33189_CR45","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1242\/dev.018200","volume":"135","author":"F Lohmann","year":"2008","unstructured":"Lohmann, F. & Bieker, J. J. Activation of eklf expression during hematopoiesis by gata2 and smad5 prior to erythroid commitment. Development 135, 2071\u20132082 (2008).","journal-title":"Development"},{"key":"33189_CR46","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/leu.2008.72","volume":"22","author":"F Cervantes","year":"2008","unstructured":"Cervantes, F., Passamonti, F. & Barosi, G. Life expectancy and prognostic factors in the classic bcr\/abl-negative myeloproliferative disorders. Leukemia 22, 905\u2013914 (2008).","journal-title":"Leukemia"},{"key":"33189_CR47","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1146\/annurev-pathol-052016-100127","volume":"12","author":"JC Aster","year":"2017","unstructured":"Aster, J. C., Pear, W. S. & Blacklow, S. C. The varied roles of notch in cancer. Annu. Rev. Pathol. 12, 245\u2013275 (2017).","journal-title":"Annu. Rev. Pathol."},{"key":"33189_CR48","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s40778-017-0090-8","volume":"3","author":"FP Lampreia","year":"2017","unstructured":"Lampreia, F. P., Carmelo, J. G. & Anjos-Afonso, F. Notch signaling in the regulation of hematopoietic stem cell. Curr. Stem Cell Rep. 3, 202\u2013209 (2017).","journal-title":"Curr. Stem Cell Rep."},{"key":"33189_CR49","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fcell.2014.00038","volume":"2","author":"F Emmert-Streib","year":"2014","unstructured":"Emmert-Streib, F., Dehmer, M. & Haibe-Kains, B. Gene regulatory networks and their applications: understanding biological and medical problems in terms of networks. Front. Cell Dev. Biol. 2, 38 (2014).","journal-title":"Front. Cell Dev. Biol."},{"key":"33189_CR50","doi-asserted-by":"crossref","unstructured":"J. Ameijeiras-Alonso, J., Crujeiras, R. M. & Rodrguez-Casal, A. Multimode: an r package for mode assessment. J. Stat. Softw. 97, 1\u201332 (2018).","DOI":"10.18637\/jss.v097.i09"},{"key":"33189_CR51","doi-asserted-by":"crossref","unstructured":"Ameijeiras-Alonso, J., Crujeiras, R. M. & Rodrguez-Casal, A. Mode testing, critical bandwidth and excess mass. Test 28, 900\u2013919 (2019).","DOI":"10.1007\/s11749-018-0611-5"},{"key":"33189_CR52","unstructured":"Therneau T. & Lumley, T. R survival package (2013)."},{"key":"33189_CR53","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"M Love","year":"2014","unstructured":"Love, M., Anders, S. & Huber, W. Differential analysis of count data\u2013the deseq2 package. Genome Biol. 15, 10\u20131186 (2014).","journal-title":"Genome Biol."},{"key":"33189_CR54","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847\u20132849 (2016).","journal-title":"Bioinformatics"},{"key":"33189_CR55","doi-asserted-by":"crossref","unstructured":"Chen T. & Guestrin, C. Xgboost: a scalable tree boosting system. In Proceedings of the 22nd acm sigkdd international conference on knowledge discovery and data mining, pp. 785\u2013794 (2016).","DOI":"10.1145\/2939672.2939785"},{"key":"33189_CR56","doi-asserted-by":"crossref","unstructured":"Benque, D. et al. Bma: Visual tool for modeling and analyzing biological networks. In International Conference on Computer Aided Verification. pp. 686\u2013692, Springer, 2012.","DOI":"10.1007\/978-3-642-31424-7_50"},{"key":"33189_CR57","unstructured":"Talarmain, L. et al. HOXA9 has the hallmarks of a biological switch with implications in blood cancer. Zenodo https:\/\/doi.org\/10.5281\/zenodo.6913664 (2022)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33189-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33189-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33189-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T23:42:07Z","timestamp":1664840527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33189-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,3]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["33189"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-33189-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.03.05.434116","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,3]]},"assertion":[{"value":"30 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5829"}}